Eradication of HIV from Tissue Reservoirs: Challenges for the Cure.

The persistence of HIV infection, even after lengthy and successful combined antiretroviral therapy (cART), has precluded an effective cure. The anatomical locations and biological mechanisms through which the viral population is maintained remain unknown. Much research has focused nearly exclusively on circulating resting T cells as the predominant source of persistent HIV, a strategy with limited success in developing an effective cure strategy. In this study, we review research supporting the importance of anatomical tissues and other immune cells for HIV maintenance and expansion, including the central nervous system, lymph nodes, and macrophages. We present accumulated research that clearly demonstrates the limitations of using blood-derived cells as a proxy for tissue reservoirs and sanctuaries throughout the body. We cite recent studies that have successfully used deep-sequencing strategies to uncover the complexity of HIV infection and the ability of the virus to evolve despite undetectable plasma viral loads. Finally, we suggest new strategies and highlight the importance of tissue banks for future research.

[1]  R. Siliciano,et al.  A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. , 2000, The Journal of clinical investigation.

[2]  S. Hughes,et al.  Multiple Origins of Virus Persistence during Natural Control of HIV Infection , 2016, Cell.

[3]  D. Margolis,et al.  Gold nanoparticles to improve HIV drug delivery. , 2015, Future medicinal chemistry.

[4]  G. Fogel,et al.  HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads , 2016, Journal of Virology.

[5]  Abraham J. Kandathil,et al.  Are T cells the only HIV-1 reservoir? , 2016, Retrovirology.

[6]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[7]  James B. Munro,et al.  Highly Active Antiretroviral Therapies Are Effective against HIV-1 Cell-to-Cell Transmission , 2014, PLoS pathogens.

[8]  R. Schinazi,et al.  Antiretroviral Therapy in Macrophages: Implication for HIV Eradication , 2009, Antiviral chemistry & chemotherapy.

[9]  R. Dewar,et al.  Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.

[10]  Q. Sattentau,et al.  High multiplicity HIV-1 cell-to-cell transmission from macrophages to CD4+ T cells limits antiretroviral efficacy , 2013, AIDS.

[11]  A. Kelleher,et al.  Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure , 2015, Front. Immunol..

[12]  R. Siliciano,et al.  HIV reservoirs: what, where and how to target them , 2015, Nature Reviews Microbiology.

[13]  Trevor Bedford,et al.  Persistent HIV-1 replication maintains the tissue reservoir during therapy , 2015, Nature.

[14]  D. Damotte,et al.  The HIV-1 viral synapse signals human foreskin keratinocytes to secrete thymic stromal lymphopoietin facilitating HIV-1 foreskin entry , 2017, Mucosal Immunology.

[15]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[16]  M. Stevenson,et al.  Apoptotic Killing of HIV-1–Infected Macrophages Is Subverted by the Viral Envelope Glycoprotein , 2007, PLoS pathogens.

[17]  R. Siliciano,et al.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.

[18]  Alan S. Perelson,et al.  Residual Viremia in Treated HIV+ Individuals , 2016, PLoS Comput. Biol..

[19]  E. Boritz,et al.  Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue. , 2017, The Journal of infectious diseases.

[20]  A. Pajot,et al.  Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. , 2006, Blood.

[21]  K. Barton,et al.  HIV-1 Reservoirs During Suppressive Therapy. , 2016, Trends in microbiology.

[22]  F. Marincola,et al.  A human memory T-cell subset with stem cell-like properties , 2011, Nature Medicine.

[23]  O. Pybus,et al.  HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer , 2016, Journal of Virology.

[24]  P. Massip,et al.  Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy. , 2014, The Journal of antimicrobial chemotherapy.

[25]  Emily B Hanhauser,et al.  Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV , 2016, PLoS pathogens.

[26]  J. Lisziewicz,et al.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.

[27]  Jeremy M. Brown,et al.  Human adipose tissue as a reservoir for memory CD4+ T cells and HIV , 2015, AIDS.

[28]  Timothy J Keyes,et al.  Structural and functional features of central nervous system lymphatics , 2015, Nature.

[29]  R. Paredes,et al.  Lack of concordance between residual viremia and viral variants driving de novo infection of CD4+ T cells on ART , 2016, Retrovirology.

[30]  S. Hughes,et al.  B-108 Specific HIV integration sites are linked to clonal expansion and persistence of infected cells , 2016 .

[31]  Narasimhan J. Venkatachari,et al.  Novel assay reveals a large inducible replication competent HIV-1 reservoir in resting CD4+ T cells , 2017, Nature Medicine.

[32]  D. Burke,et al.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes , 1988, The Journal of experimental medicine.

[33]  John M. Coffin,et al.  Clonal Sequences Recovered from Plasma from Patients with Residual HIV-1 Viremia and on Intensified Antiretroviral Therapy Are Identical to Replicating Viral RNAs Recovered from Circulating Resting CD4+ T Cells , 2011, Journal of Virology.

[34]  M. Dierich,et al.  Astrocytes and Neurons Virus-induced Complement Expression in Mechanism of Human Immunodeficiency , 2001 .

[35]  R. Paredes,et al.  Deep Molecular Characterization of HIV-1 Dynamics under Suppressive HAART , 2011, PLoS pathogens.

[36]  Ron Milo,et al.  Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy , 2011, Nature.

[37]  I. Elovaara,et al.  Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia , 1995, AIDS.

[38]  S. Hughes,et al.  Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo , 2016, Proceedings of the National Academy of Sciences.

[39]  M. Suchard,et al.  Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models. , 2011, Molecular biology and evolution.

[40]  Geneviève Boucher,et al.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.

[41]  P. Lemey,et al.  HIV evolutionary dynamics within and among hosts. , 2006, AIDS reviews.

[42]  Alan S Perelson,et al.  Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues , 2014, Proceedings of the National Academy of Sciences.

[43]  S. Little,et al.  Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations , 2017, PLoS pathogens.

[44]  Marco Salemi,et al.  HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. , 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[45]  Q. Sattentau,et al.  Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. , 2008, Blood.

[46]  C. Costiniuk,et al.  Cell-to-cell transfer of HIV infection: implications for HIV viral persistence. , 2014, The Journal of general virology.

[47]  M. Stevenson,et al.  Macrophages archive HIV‐1 virions for dissemination in trans , 2005, The EMBO journal.

[48]  C. Rouzioux,et al.  Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection , 2015, PLoS pathogens.

[49]  A. Haase,et al.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.

[50]  Steven G. Deeks,et al.  Persistent HIV-1 replication during antiretroviral therapy , 2016, Current opinion in HIV and AIDS.

[51]  J. Kappes,et al.  High-Multiplicity HIV-1 Infection and Neutralizing Antibody Evasion Mediated by the Macrophage-T Cell Virological Synapse , 2013, Journal of Virology.

[52]  R. Schinazi,et al.  Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages , 2012, Antimicrobial Agents and Chemotherapy.

[53]  D. Persaud,et al.  Paucity of Intact Non-Induced Provirus with Early, Long-Term Antiretroviral Therapy of Perinatal HIV Infection , 2017, PloS one.

[54]  J. Clements,et al.  Expression of Simian Immunodeficiency Virus (SIV) Nef in Astrocytes during Acute and Terminal Infection and Requirement of Nef for Optimal Replication of Neurovirulent SIV In Vitro , 2003, Journal of Virology.

[55]  J. Martinez-Picado,et al.  Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue , 2017, PloS one.

[56]  Beata J. Wysocki,et al.  Endosomal Trafficking of Nanoformulated Antiretroviral Therapy Facilitates Drug Particle Carriage and HIV Clearance , 2014, Journal of Virology.

[57]  Nancie M Archin,et al.  Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents. , 2017, The Journal of infectious diseases.

[58]  T. Henrich,et al.  Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies. , 2017, The Journal of infectious diseases.

[59]  E. Rosenberg,et al.  HIV-1 persistence in CD4+ T cells with stem cell-like properties , 2014, Nature Medicine.

[60]  A. Chakraborty,et al.  Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA , 2016, Proceedings of the National Academy of Sciences.

[61]  Brendan B. Larsen,et al.  Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection , 2014, Science.

[62]  J. Mellors,et al.  Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells , 2017, PLoS pathogens.

[63]  Amit Kumar,et al.  HIV-1 Latency in Monocytes/Macrophages , 2014, Viruses.

[64]  Konrad Scheffler,et al.  Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy , 2016, Virus evolution.

[65]  P. Lemey,et al.  The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time , 2013, Proceedings of the National Academy of Sciences.

[66]  G. Fogel,et al.  Prediction of R5, X4, and R5X4 HIV-1 Coreceptor Usage with Evolved Neural Networks , 2008, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[67]  Sylvia Silver,et al.  The AIDS and Cancer Specimen Resource. , 2011, Methods in molecular biology.

[68]  J. Kappes,et al.  Macrophage Infection via Selective Capture of HIV-1-Infected CD4+ T Cells , 2014, Cell host & microbe.

[69]  R. Schinazi,et al.  HCV drug discovery aimed at viral eradication , 2010, Journal of Viral Hepatitis.

[70]  H. Schuitemaker,et al.  Interference of interleukin-10 with human immunodeficiency virus type 1 replication in primary monocyte-derived macrophages , 1994, Journal of virology.

[71]  A. Sigal,et al.  HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell , 2016, PLoS pathogens.

[72]  S. Hughes,et al.  Specific HIV integration sites are linked to clonal expansion and persistence of infected cells , 2014, Science.

[73]  F. Forouzanfar,et al.  Targeting the Brain Reservoirs: Toward an HIV Cure , 2016, Front. Immunol..

[74]  J. Mellors,et al.  Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy , 2014, PLoS pathogens.

[75]  J. Mullins,et al.  An Increasing Proportion of Monotypic HIV-1 DNA Sequences during Antiretroviral Treatment Suggests Proliferation of HIV-Infected Cells , 2012, Journal of Virology.

[76]  The meningeal lymphatic system: a route for HIV brain migration? , 2016, Journal of NeuroVirology.